NEWSROOM

BIO

Proyectos emblemáticos de la industria de biocombustibles en Brasil 2024

Proyectos emblemáticos de la industria de biocombustibles en Brasil 2024

Proyectos emblemáticos de la industria de biocombustibles en Brasil 2024 Solicite la lista completa New York, septiembre 2024 - PRISM MediaWire - Antes del Foro Internacional de Inversiones Biofuels Brazil 2024, Vostock Capital ha preparado un informe que presenta la lista completa de los proyectos emblemáticos de la industria de biocombustibles en Brasil, que se discutirán más a fondo en el evento. Entre los proyectos: • EXPANSIÓN DE PRODUCCIÓN DE ETANOL Empresa: Atvos, Inversión: US $920 M •...

read more
Flagship projects of Biofuels industry in Brazil 2024

Flagship projects of Biofuels industry in Brazil 2024

Flagship projects of Biofuels industry in Brazil 2024 Request the full list New York, September 2024 - PRISM MediaWire - Before International Investment Forum Biofuels Brazil 2024, Vostock Capital has prepared a report featuring the complete list of flagship projects of the Biofuels industry in Brazil, which will be further discussed at the event.Among the projects:  ETHANOL PRODUCTION EXPANSION Company: Atvos, Investment: US $920 M CORN ETHANOL IN CAMPO MOURAO Company: Coamo...

read more
Prospects for the Development of the Biofuels Industry in Brazil: Sustainable Future and Growth Opportunities

Prospects for the Development of the Biofuels Industry in Brazil: Sustainable Future and Growth Opportunities

New York, July 2, 2024 - VoStock Capital in cooperation with Biofuels Brazil (International Investment Forum) is thrilled to invite you to the free webinar devoted to Prospects for the development of the industry of Biofuels Brazil.The webinar will be held on July 5th at 3 pm (UTC-3) São Paulo, Brazil time. The webinar will be held in English. Register for the free webinar  The webinar will feature distinguished experts as speakers: Ruy Campos Dugone, Executive Director of Green Cross...

read more
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay

-     Bio-Rad expects to make equity investment in support of deal -     Agreement provides for global exclusivity in transplant monitoring commercialization -     Bio-Rad granted subsequent investment option upon FDA clearance IRVINE, CA, April 11, 2024 - Oncocyte Corporation (NASDAQ: OCX), a precision diagnostics company, today announced a partnership agreement with Bio-Rad Laboratories (NYSE: BIO), a global leader in life science research and clinical diagnostics products, for the...

read more

Contact Us

PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850